Zurcher Kantonalbank (Zurich Cantonalbank) Cytokinetics Inc Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $39 Billion
- Q2 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Cytokinetics Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 32,255 shares of CYTK stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,255
Previous 29,261
10.23%
Holding current value
$1.84 Million
Previous $1.18 Million
9.36%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CYTK
# of Institutions
370Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$836 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$683 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$446 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$363 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.36B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...